These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 20164087)

  • 1. Dynamics of infectious disease transmission by inhalable respiratory droplets.
    Stilianakis NI; Drossinos Y
    J R Soc Interface; 2010 Sep; 7(50):1355-66. PubMed ID: 20164087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatial dynamics of airborne infectious diseases.
    Robinson M; Stilianakis NI; Drossinos Y
    J Theor Biol; 2012 Mar; 297():116-26. PubMed ID: 22207025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High infectivity and pathogenicity of influenza A virus via aerosol and droplet transmission.
    Teunis PF; Brienen N; Kretzschmar ME
    Epidemics; 2010 Dec; 2(4):215-22. PubMed ID: 21352792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-range airborne transmission of expiratory droplets between two people.
    Liu L; Li Y; Nielsen PV; Wei J; Jensen RL
    Indoor Air; 2017 Mar; 27(2):452-462. PubMed ID: 27287598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of droplet dispersion during non-invasive ventilation, oxygen therapy, nebuliser treatment and chest physiotherapy in clinical practice: implications for management of pandemic influenza and other airborne infections.
    Simonds AK; Hanak A; Chatwin M; Morrell M; Hall A; Parker KH; Siggers JH; Dickinson RJ
    Health Technol Assess; 2010 Oct; 14(46):131-172. PubMed ID: 20923611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral kinetics and exhaled droplet size affect indoor transmission dynamics of influenza infection.
    Chen SC; Chio CP; Jou LJ; Liao CM
    Indoor Air; 2009 Oct; 19(5):401-13. PubMed ID: 19659895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How far droplets can move in indoor environments--revisiting the Wells evaporation-falling curve.
    Xie X; Li Y; Chwang AT; Ho PL; Seto WH
    Indoor Air; 2007 Jun; 17(3):211-25. PubMed ID: 17542834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of face shields against cough aerosol droplets from a cough simulator.
    Lindsley WG; Noti JD; Blachere FM; Szalajda JV; Beezhold DH
    J Occup Environ Hyg; 2014; 11(8):509-18. PubMed ID: 24467190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Droplets and aerosols: An artificial dichotomy in respiratory virus transmission.
    Drossinos Y; Weber TP; Stilianakis NI
    Health Sci Rep; 2021 Jun; 4(2):e275. PubMed ID: 33977157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aerosol Dynamics Model for Estimating the Risk from Short-Range Airborne Transmission and Inhalation of Expiratory Droplets of SARS-CoV-2.
    Dhawan S; Biswas P
    Environ Sci Technol; 2021 Jul; 55(13):8987-8999. PubMed ID: 34132519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative contributions of four exposure pathways to influenza infection risk.
    Nicas M; Jones RM
    Risk Anal; 2009 Sep; 29(9):1292-303. PubMed ID: 19558389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmission risk of infectious droplets in physical spreading process at different times: A review.
    Mao N; An CK; Guo LY; Wang M; Guo L; Guo SR; Long ES
    Build Environ; 2020 Nov; 185():107307. PubMed ID: 33519041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viable influenza A virus in airborne particles expelled during coughs versus exhalations.
    Lindsley WG; Blachere FM; Beezhold DH; Thewlis RE; Noorbakhsh B; Othumpangat S; Goldsmith WT; McMillen CM; Andrew ME; Burrell CN; Noti JD
    Influenza Other Respir Viruses; 2016 Sep; 10(5):404-13. PubMed ID: 26991074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing coughing-induced influenza droplet transmission and implications for infection risk control.
    Cheng YH; Wang CH; You SH; Hsieh NH; Chen WY; Chio CP; Liao CM
    Epidemiol Infect; 2016 Jan; 144(2):333-45. PubMed ID: 26211781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of saliva fluid properties on pathogen transmissibility.
    Reyes J; Fontes D; Bazzi A; Otero M; Ahmed K; Kinzel M
    Sci Rep; 2021 Aug; 11(1):16051. PubMed ID: 34362974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure to influenza virus aerosols during routine patient care.
    Bischoff WE; Swett K; Leng I; Peters TR
    J Infect Dis; 2013 Apr; 207(7):1037-46. PubMed ID: 23372182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of influenza A viruses in the environment and modes of transmission: a critical review.
    Weber TP; Stilianakis NI
    J Infect; 2008 Nov; 57(5):361-73. PubMed ID: 18848358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Informing optimal environmental influenza interventions: how the host, agent, and environment alter dominant routes of transmission.
    Spicknall IH; Koopman JS; Nicas M; Pujol JM; Li S; Eisenberg JN
    PLoS Comput Biol; 2010 Oct; 6(10):e1000969. PubMed ID: 21060854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Airborne transmission of severe acute respiratory syndrome coronavirus-2 to healthcare workers: a narrative review.
    Wilson NM; Norton A; Young FP; Collins DW
    Anaesthesia; 2020 Aug; 75(8):1086-1095. PubMed ID: 32311771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantifying the routes of transmission for pandemic influenza.
    Atkinson MP; Wein LM
    Bull Math Biol; 2008 Apr; 70(3):820-67. PubMed ID: 18278533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.